Andrews William T. bought CPRX
November 20, 2025 · Form 4 insider transaction
Andrews William T. bought 29,776 shares of Catalyst Pharmaceuticals Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
29,776
Price
$0.00
Total value
N/A
InsiderAndrews William T.
Role—
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateNovember 20, 2025
Filing dateNovember 24, 2025
Shares owned after268,136
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.; Derivative securities vest in equal tranches, 1/3rd on November 20, 2026, 1/3rd on November 20, 2027 and 1/3rd on November 20, 2028.; Shares of common stock will be delivered to the Reporting Person upon vesting.